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The biologic activity of retinoids is mediated through
nuclear retinoic acid receptors (RAR), which are ligand-
activated transcription factors. RAR directly bind and
are activated by two naturally occurring isomers of
retinoic acid (RA), all-trans retinoic acid (t-RA) and 9-
cis retinoic acid (9c-RA). Human skin predominantly
expresses RAR-g (µ87%) and RAR-a makes up the
remainder. Recombinant RAR-g preferentially binds t-
RA over 9c-RA in cell-free assays containing mixtures of
the two retinoic acid isomers. We have investigated the
ligand-binding properties of RAR in human epidermis.
[3H]All-trans retinol (t-ROL) added to suspensions of
intact epidermal cells was metabolically converted to
[3H]t-RA, which bound to RAR. No binding of [3H]9c-
RA to RAR was detected. Binding of [3H]t-RA, formed
from [3H]t-ROL, was abolished by adding unlabeled t-
RA, but was unaffected by adding unlabeled 9c-RA.
Intact epidermal cells were incubated with mixtures of
[3H]9c-RA and [3H]t-RA in varying ratios, and the
amount of each labeled retinoid bound to RAR was
measured. At ratios of 9c-RA to t-RA of 3:1 or lower,
only [3H]t-RA was bound by RAR. Incubation of cells
Retinol (vitamin A) plays a critical role in the growthand differentiation of mammalian skin in both adultand fetal tissues (Thomson et al, 1964; Roberts andSporn, 1984; Smith et al, 1987; Thaller and Eichele,1987; Chambon, 1996). In adult human skin, retinol
is metabolized to its biologically active form, retinoic acid (RA)
(Thomson et al, 1964; Kurlandsky et al, 1994; Kang et al, 1995).
The physiologic actions of retinoids are mediated through nuclear
receptors that regulate transcription of target genes (Evans, 1988;
Green and Chambon, 1988; Zelent et al, 1991; Chambon, 1993).
Two families of nuclear receptors, belonging to the steroid/thyroid
hormone superfamily (Evans, 1988), have been identified: these are
the retinoid X receptors (RXR) and the retinoic acid receptors
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with [3H]9c-RA alone resulted in substantial (38%) bind-
ing of [3H]t-RA to RAR, in addition to binding of [3H]9c-
RA, due to isomerization of [3H]9c-RA to [3H]t-RA.
RAR in nuclear extracts from epidermal cells also dis-
played strong preferential binding of t-RA over 9c-RA.
Competition studies revealed that 9c-RA was 6-fold less
effective than t-RA at displacing [3H]t-RA bound to RAR
in nuclear extracts. At ratios of 9c-RA to t-RA of 4:1 or
lower, RAR in nuclear extracts bound t-RA exclusively.
At higher ratios, [3H]9c-RA binding increased steeply.
RAR-a in nuclear extracts bound both 9c-RA and t-RA
without preference, whereas RAR-g displayed strong
preferential binding of t-RA over 9c-RA. The level of
endogenous t-RA exceeds that of 9c-RA in human skin
in vivo, and significant isomerization of topically applied
9c-RA and 13c-RA to t-RA occurs. The relative abund-
ance of t-RA in human skin, and preferential binding of
t-RA by RAR-γ, indicate that t-RA is the primary ligand
mediating RAR-dependent responses in human skin
under physiologic conditions, and under pharmacologic
conditions when t-RA, 9c-RA, or 13c-RA are applied
to skin. Key words: isomerization/RAR-α/RAR-γ/retinoids.
J Invest Dermatol 110:297–300, 1998
(RAR). Each family includes three subtypes: RXR-α, RXR-β,
and RXR-γ, and RAR-α, RAR-β, and RAR-γ, respectively
(Evans, 1988; Zelent et al, 1991; Allenby et al, 1993; Mangelsdorf
et al, 1994).
All-trans RA (t-RA) and 9-cis RA (9c-RA), two naturally occurr-
ing, biologically active stereoisomers of RA, function as ligands for
nuclear retinoid receptors (Heyman et al, 1992; Levin et al, 1992).
RXR bind 9c-RA with high affinity (Levin et al, 1992), but bind
t-RA only very weakly (Allenby et al, 1993). RAR bind t-RA and
9c-RA with similar high affinity (Allenby et al, 1993). Under ambient
conditions, t-RA, 9c-RA, and 13-cis RA (13c-RA) (which does not
bind either RAR or RXR) are interconverted through isomerization.
Mangelsdorf et al (1994) have proposed that 9c-RA may be
functionally distinct from t-RA and that interconversion of the two
isomers could provide a basis for differential, cell-specific regulation
of the activity of the two retinoid pathways.
Using transfected COS cells (a transformed green monkey kidney
cell line), Allenby et al (1994) have recently shown that, in the
presence of a mixture of t-RA and 9c-RA, recombinant RAR-γ,
but not RAR-α or RAR-β, preferentially binds t-RA. Competitive
binding assays conducted with both nucleosol fractions and intact
COS-1 cells, transiently transfected with human RAR subtypes,
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showed that unlabeled 9c-RA was much less potent than unlabeled
t-RA in displacing bound [3H]t-RA from RAR-γ.
In human epidermis, RAR-γ is the predominant RAR, accounting
for µ87% of RAR protein. RAR-α makes up the remainder.
RAR-β is not detectable (Fisher et al, 1994). In this study, we
examined binding of t-RA and 9c-RA by RAR in human epidermis.
This study represents an important departure from previous studies:
we focus on human skin under in vivo conditions, instead of using
transformed, transfected cell lines of nonhuman, nonskin origin. We
demonstrate that RAR-γ in human epidermis preferentially binds t-
RA over 9c-RA when presented with mixtures of the two isomers.
It has recently been demonstrated that endogenous levels of t-RA
exceed those of 9c-RA in human skin, and that substantial amounts
of 9c-RA and 13c-RA isomerize to t-RA within 2 d of topical
administration to human skin (Duell et al, 1996). Taken together,
these data indicate that t-RA is the primary ligand that mediates
RAR-dependent responses in human skin in vivo, under physiologic
and pharmacologic conditions, when t-RA, 9c-RA, or 13c-RA are
topically applied.
MATERIALS AND METHODS
Materials [11,123H(N)]9c-RA and unlabeled 9c-RA were generously
provided by Drs. P.F. Sorter, J.F. Grippo, and A. A. Levin (Hoffmann-La
Roche, Nutley, NJ). t-RA was obtained from Sigma (St. Louis, MO).
[11,123H(N)]t-RA and [11,123H(N)]t-ROL were obtained from Dupont
NEN (Boston, MA). SRI 11237, originally synthesized by Dr. M.I. Dawson
(Lehmann et al, 1992), was provided by B. Janssen (BASF, Ludwigshafen,
Germany). Protein A Sepharose CL4B was obtained from Pharmacia LKB
(Piscataway, NJ). PD-10 columns for size-exclusion chromatography were
also obtained from Pharmacia.
Procurement of human skin biopsies Keratome biopsies were obtained
from healthy adult human volunteers, as previously described (Fisher et al,
1991). All procedures involving human subjects were approved by the
University of Michigan Institutional Review Board, and all subjects provided
written informed consent.
Preparation of epidermal cell suspensions Keratome biopsies were
placed in 0.25% trypsin, 0.1% ethylenediamine tetraacetic acid for 40 min
at 37°C. Trypsinization was stopped by the addition of Dulbecco’s modified
Eagle’s medium containing 10% fetal bovine serum. Cells were released
from the tissue by scraping. Cell suspensions were passed through a nylon
filter to remove residual tissue, and washed twice in serum-free Dulbecco’s
modified Eagle’s medium.
Preparation of nuclear extracts Epidermal cells (about 2 3 108) were
washed twice in phosphate-buffered saline and resuspended in 1 ml of buffer
(20 mM Tris, pH 8, 20 mM NaCl, 6 mM MgCl2, 0.2% Triton X-100,
1 mM dithiothreitol, 200 mM sucrose, 1 mM phenylmethylsulfonyl fluoride,
0.02 mg leupeptin per ml, and 0.02 mg pepstatin per ml). Nuclear extracts
containing RAR were prepared as described previously (Fisher et al, 1994).
Incubation of epidermal cells and nuclear extracts with
retinoids Intact epidermal cells (5 3 107 cells per ml) suspended in serum-
free Dulbecco’s modified Eagle’s medium (3 ml) were incubated with [3H]t-
ROL (50 nM and 2 3 106 cpm) (the metabolic precursor of RA), [3H]t-
RA, or [3H]9c-RA for 3 h at 37°C. In addition, cells were incubated with
mixtures of labeled t-RA and 9c-RA in varying ratios. In these mixtures,
total ligand concentration (i.e., t-RA plus 9c-RA) and specific radioactivity
remained constant at 10 nM and 5 3 105 cpm. When cells were incubated
with [3H]t-RA or [3H]9c-RA alone, the ligand concentration and specific
radioactivity were 10 nM and 5 3 105 cpm, respectively, in each case. All
incubations were performed in the presence of a saturating concentration
(50 µM) of SRI 11237, a synthetic retinoid that binds exclusively to RXR
(Lehmann et al, 1992; Fisher et al, 1994). Inclusion of SRI 11237 served to
occupy all ligand-binding sites on RXR in intact epidermal cells, thereby
enabling measurement of [3H]t-RA and [3H]9c-RA binding to RAR without
interference from RXR binding. Following incubation, nuclear extracts were
prepared as described above. Nuclear extracts (300 µg) from epidermal cells
were incubated for 3 h at 4°C, with varying ratios of [3H]t-RA and [3H]9c-
RA, in the presence of an excess of unlabeled SRI 11237, as described above.
Immunoprecipitation of RAR-a and RAR-g Nuclear extracts (300 µg
protein per 100 µl) were incubated with 50 µl (5 µg) polyclonal antibody
to RAR-α or RAR-γ for 2 h at 4°C, with constant shaking. Protein A
Figure 1. Human epidermal cells metabolize t-ROL to t-RA, which
binds to RAR. Epidermal cells (5 3 107 cells per ml) were prepared from
keratome biopsies and incubated with [3H]t-ROL (50 nM and 2 3 106
cpm), alone or in the presence of unlabeled t-RA (2 µM) or 9c-RA
(2 µM), for 3 h at 37°C. Fifty micromoles SRI 11237 was added to all
assays to saturate RXR. Nuclear extracts were prepared, and [3H]retinoids
bound to RAR were quantitated by HPLC, as described in Materials and
Methods. r, [3H]t-RA bound to RAR; u (barely visible to the right of
each hatched bar), [3H]9c-RA bound to RAR. Results are means 6 SEM
of six experiments.
Sepharose (100 µl) was added and the resultant mixture was incubated for
1 h at 4°C. Immune complexes bound to protein Sepharose were pelleted
by centrifugation at 10,000 3 g for 10 min. The resulting supernatants were
used for binding analysis.
Analysis of retinoids bound to epidermal RAR Following incubation
with labeled retinoids, nuclear extracts were passed through PD-10 size
exclusion columns to separate bound from unbound ligands. Bound labeled
retinoids, which eluted in the column void volume, were extracted in
chloroform:methanol (2:1). Extracted retinoids were resolved and quantitated
using reverse phase high performance liquid chromatography (HPLC) analysis,
with in-line radioactive detection, as described previously (Duell et al, 1996).
RESULTS
Human epidermal cells metabolize all-trans retinol (t-ROL)
to t-RA, which binds to RAR Intact epidermal cells were
incubated with [3H]t-ROL, and labeled retinoids bound to RAR
were determined by HPLC. As Fig 1 illustrates, the only labeled
retinoid that was detected bound to RAR was [3H]t-RA. No
binding of [3H]9c-RA or [3H]13c-RA to RAR was detected.
Incubation of cells with equal concentrations (1 µM) of [3H]t-ROL
and unlabeled t-RA resulted in substantial (.90%) reduction in
[3H]t-RA binding to RAR, and no detectable binding of [3H]9c-
RA (Fig 1). In contrast, incubation of cells with equal concentrations
(1 µM) of [3H]t-ROL and unlabeled 9c-RA resulted in a minor
(20%) and variable reduction in [3H]t-RA binding to RAR. These
data demonstrate that human epidermal cells metabolize [3H]t-ROL
to [3H]t-RA, which binds to RAR, without any detectable binding
of [3H]9c-RA or [3H]13c-RA.
Failure of unlabeled 9c-RA, but not t-RA, to effectively diminish
binding of [3H]t-RA, formed from [3H]t-ROL, to RAR could
have reflected either preferential binding of t-RA over 9c-RA by
epidermal RAR, or low uptake of 9c-RA, relative to t-RA, by
epidermal cells. To decide between these possibilities, we incubated
intact epidermal cells with mixtures of [3H]t-RA and [3H]9c-RA
in varying ratios. [3H]retinoids bound to RAR were quantitated by
HPLC. Addition of [3H]t-RA alone resulted in exclusive (100%)
binding of [3H]t-RA, with no detectable binding of [3H]9c-RA
(Fig 2, first pair of bars). Incubation of cells with 1:1 and 1:3
mixtures of [3H]t-RA:[3H]9c-RA also resulted in exclusive binding
of [3H]t-RA (Fig 2, second and third pairs of bars, respectively).
Remarkably, even when cells were incubated with 100% [3H]9c-
RA, 38 6 3.1% of the bound ligand was still [3H]t-RA, whereas
62 6 3.1% was [3H]9c-RA (Fig 2). In these experiments, total cell-
associated [3H]retinoid was similar, irrespective of the ratio of [3H]t-
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Figure 2. Human epidermal RAR preferentially bind t-RA. Epidermal
cells (5 3 107 cells per ml) were prepared from keratome biopsies, and
incubated with mixtures of [3H]t-RA and [3H]9c-RA in varying ratios
([3H]t-RA alone, 1:1 and 1:3 mixtures of [3H]t-RA:[3H]9c-RA, and [3H]9c-
RA alone), for 3 h at 37°C. In these mixtures, total ligand concentration
(i.e., [3H]t-RA plus [3H]9c-RA) and specific radioactivity remained constant
at 10 nM and 5 3 105 cpm, respectively. Nuclear extracts were prepared,
and [3H]retinoids bound to RAR were quantitated by HPLC, as described
in Materials and Methods. ‘‘Added’’ refers to the percentage of [3H]t-RA (r)
and [3H]9-cis RA (u) incubated with epidermal cells. ‘‘Bound’’ refers to
the percentage of [3H]t-RA (r) and [3H]9-cis RA (u) detected bound to
RAR. Results are means 6 SEM of four experiments. In each of four
experiments, addition of [3H]t-RA alone (left bar of first pair of bars), a 50:50
ratio of [3H]t-RA:[3H]9c-RA (left bar of second pair of bars), and a 25:75
ratio of [3H]t-RA:[3H]9c-RA (left bar of third pair of bars) resulted in exclusive
(100%) binding of [3H]t-RA by total RAR (right bar of first, second, and
third pairs of bars). Addition of [3H]9c-RA alone (right bar of fourth pair of
bars) resulted in binding of both [3H]9c-RA and [3H]t-RA (left bar of fourth
pair of bars).
RA to [3H]9c-RA, indicating that cellular uptake of the two
retinoids was similar (data not shown).
The finding that substantial amounts of t-RA bind to RAR in
cells incubated with [3H]9c-RA suggests that 9c-RA isomerizes to
t-RA in epidermal cells. To determine the extent to which
isomerization of 9c-RA to t-RA occurred during incubation of cells
with [3H]9c-RA, total cellular and nuclear [3H]retinoids were
extracted and quantitated following incubation of cells with [3H]9c-
RA. The ratio of [3H]9c-RA to [3H]t-RA in whole cells and
nuclear extracts was 61 6 4:39 6 4 (n 5 2) and 58 6 1.5:42 6 1.5
(n 5 2), respectively. The [3H]9c-RA used for these studies contained
less than 1% t-RA. These data indicate that significant isomerization
of 9c-RA to t-RA occurred in epidermal cells. No 9c-RA was
detected in either whole cells or nuclear extracts from cells incubated
with [3H]t-RA.
Epidermal RAR preferentially bind t-RA We next prepared
nuclear extracts containing RAR from human epidermal cells, and
performed competitive ligand-binding assays. Increasing concentra-
tions of unlabeled t-RA effectively displaced [3H]t-RA (10 nM)
from human skin RAR, with 50% displacement (IC50) occurring
at 10 nM (Fig 3). In contrast, 10 nM 9c-RA displaced only about
10% of [3H]t-RA. The calculated IC50 of 9c-RA for displacement
of [3H]t-RA was seven times higher (70 nM) than that of t-RA.
These data are consistent with those obtained for intact epidermal
cells, indicating preferential binding of t-RA versus 9c-RA.
RAR-γ in human epidermis preferentially binds t-RA versus
9c-RA Finally, we examined direct binding of mixtures of [3H]t-
RA and [3H]9c-RA, in varying ratios, to total and individual RAR
subtypes in epidermal cell nuclear extracts. At ratios of t-RA:9c-
RA between 100:0 and 20:80, total RAR bound exclusively t-RA
(Fig 4). As the proportion of 9c-RA increased from 80% to 100%,
binding of 9c-RA increased sharply, with a concomitant decrease in
t-RA binding (Fig 4). Epidermal nuclear extracts contain both
Figure 3. t-RA is a better competitor than 9c-RA for [3H]t-RA
binding to RAR in nuclear extracts from human epidermis. Nuclear
extracts containing RAR were prepared from human epidermal cells (about
2 3 108). [3H]t-RA (10 nM) was incubated with the indicated concentrations
of unlabeled t-RA or 9c-RA for 3 h at 4°C, as described in Materials and
Methods. The degree of displacement of [3H]t-RA from RAR was measured
by HPLC, as described in Materials and Methods. (r) [3H]t-RA bound to
RAR in the presence of unlabeled t-RA; (u) [3H]t-RA bound to RAR
in the presence of unlabeled 9c-RA. Results are means 6 SEM of three
experiments.
Figure 4. RAR-g, but not RAR-a in human skin nuclear extracts
preferentially binds t-RA versus 9c-RA. Nuclear extracts containing RAR
were prepared from human epidermal cells (about 2 3 108). RAR-α and
RAR-γ were separately removed by immunoprecipitation to allow
measurement of ligand binding to RAR-γ and RAR-α, respectively.
Mixtures of [3H]t-RA and [3H]9c-RA in the varying ratios indicated on
the x-axis were incubated with total or individual RAR subtypes for 3 h
at 4°C, and labeled ligands bound to RAR were determined by HPLC, as
described in Materials and Methods. - - - - and 1, RAR-α; –·–·–· and u,
RAR-γ; –––– and d, total RAR. Note that j indicates overlap between
d and u. Results are means 6 SEM of three experiments.
RAR-α and RAR-γ (Fisher et al, 1994). RAR-α and RAR-γ were
separately removed by immunoprecipitation to enable measurement
of t-RA and 9c-RA binding to the two individual receptor subtypes.
RAR-γ displayed a strong preference for t-RA versus 9c-RA (Fig 4),
similar to that observed in intact epidermal cells and nuclear extracts.
No significant binding of 9c-RA by RAR-γ occurred until the
proportion of 9c-RA reached 90%. In contrast, RAR-α displayed
no preferential binding of either t-RA or 9c-RA, binding each
ligand in proportion to its relative amount (Fig 4). For example,
RAR-α incubated with a 1:1 mixture of t-RA and 9c-RA bound
nearly equal amounts of the two ligands.
DISCUSSION
Human epidermis expresses predominately RAR-γ (87%) with lesser
amounts of RAR-α (13%) (Fisher et al, 1994). Human epidermal
nuclear extracts containing these two RAR subtypes separately bind
t-RA and 9c-RA with similar high affinity (Fisher et al, 1994). The
data presented above, however, demonstrate that intact human
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epidermal cells and human epidermal cell nuclear extracts display
strong preferential binding of t-RA versus 9c-RA in the presence of
mixtures of the two ligands. This preferential binding of t-RA was
attributable to RAR-γ, the major RAR form in human epidermis.
RAR-α in human epidermis exhibited no preference for either
ligand, binding t-RA and 9c-RA in proportion to their relative
concentrations in mixtures of the two ligands.
Allenby et al (1993) have reported that recombinant mouse RAR-
γ, but not RAR-α or RAR-β, expressed in COS cells preferentially
bound t-RA over 9c-RA in mixtures of the two ligands. This
preference for t-RA by RAR-γ was found to result from t-RA
having a slower off-rate, compared with 9c-RA. Thus, once t-RA
binds to RAR-γ, it remains bound for a longer time than 9c-RA
before it dissociates. This difference in off-rates between t-RA and
9c-RA is such that, at equilibrium, in the presence of mixtures of
t-RA and 9c-RA, very little 9c-RA is bound to RAR-γ, unless the
concentration of 9c-RA exceeds that of t-RA by at least 5-fold.
Preferential binding of t-RA versus 9c-RA by RAR-γ is an
inherent property of the structure of the ligand-binding domain of
the receptor. RAR subtypes are highly conserved between species
(Zelent et al, 1991; Leid et al, 1992); the amino acid sequence of
the ligand-binding domain of mouse RAR-γ exhibits 100%
homology with that of human RAR-γ. Thus, the slower off-rate
of t-RA versus 9c-RA observed for mouse RAR-γ likely explains
the observed preferential binding of t-RA by human epidermal
RAR-γ. t-RA and 9c-RA bind overlapping yet distinct sites on
RAR (Tate et al, 1994). This may contribute to the observed
difference in the kinetics of binding of these two ligands.
Human epidermal cells metabolize t-ROL to t-RA, which binds
to RAR. No binding of 9c-RA, formed from t-ROL, was detected.
The lack of detectable 9c-RA binding was due not only to
preferential binding of t-RA by RAR-γ, but also to the very low
level of isomerization of t-RA, formed from t-ROL, to 9c-RA.
This observation is consistent with recent findings that 48 h after
topical application, only 1% of t-RA has isomerized to 9c-RA in
human skin (Duell et al, 1996). It has been suggested that formation
of 9c-RA through biosynthesis from 9c-ROL and/or isomerization
of t-RA may represent a distinct retinoid signaling pathway (Heyman
et al, 1992; Levin et al, 1992; Allenby et al, 1993). To date, however,
there is no direct evidence for enzymatic formation of 9c-RA from
either 9c-ROL or t-RA.
Endogenous levels of t-RA exceed those of 9c-RA in human
skin (Duell et al, 1996). In addition, within 48 h of topical application
of 9c-RA, the ratio of 9c-RA to t-RA in human skin is 52:36,
due to isomerization of 9c-RA to t-RA (Duell et al, 1996). As
shown above, at this ratio of the two ligands, RAR-γ would bind
t-RA exclusively. Topically applied 13c-RA isomerizes predominantly
to t-RA in human skin (Duell et al, 1996). Because 13c-RA does
not bind RAR (Allenby et al, 1993), t-RA must therefore mediate
RAR-dependent responses to 13c-RA.
Given that, in human skin, (i) levels of t-RA exceed those of
9c-RA (Duell et al, 1996), (ii) RAR-γ is predominant (87%) (Fisher
et al, 1994), (iii) topically applied retinol is, to a great extent,
metabolized to the all-trans isomer (Duell et al, 1996), and (iv)
RAR-γ preferentially binds t-RA over 9c-RA (this study), we
conclude that t-RA is the predominant ligand that binds to RAR
and therefore must be the major mediator of RAR-dependent
responses in human skin under both physiologic and pharmacologic
conditions, when t-RA, 9c-RA, or 13c-RA are applied.
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